.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
McKinsey
Baxter
Novartis
Moodys
Daiichi Sankyo
McKesson
Cantor Fitzgerald
Julphar
Cipla

Generated: July 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020833

« Back to Dashboard
NDA 020833 describes FLOVENT DISKUS 50, which is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the FLOVENT DISKUS 50 profile page.

The generic ingredient in FLOVENT DISKUS 50 is fluticasone propionate. There are twenty-four drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.

Summary for NDA: 020833

Tradename:
3
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Respiratory Tract Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 020833

Suppliers and Packaging for NDA: 020833

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FLOVENT DISKUS 100
fluticasone propionate
POWDER;INHALATION 020833 NDA GlaxoSmithKline LLC 0173-0600 0173-0600-02 1 INHALER in 1 CARTON (0173-0600-02) > 60 POWDER, METERED in 1 INHALER
FLOVENT DISKUS 100
fluticasone propionate
POWDER;INHALATION 020833 NDA GlaxoSmithKline LLC 0173-0601 0173-0601-00 1 INHALER in 1 CARTON (0173-0601-00) > 28 POWDER, METERED in 1 INHALER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;INHALATIONStrength0.05MG/INH
Approval Date:Sep 29, 2000TE:RLD:Yes
Patent:► SubscribePatent Expiration:Aug 23, 2016Product Flag?Substance Flag?Delist Request?

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:POWDER;INHALATIONStrength0.1MG/INH
Approval Date:Sep 29, 2000TE:RLD:Yes
Patent:► SubscribePatent Expiration:Aug 23, 2016Product Flag?Substance Flag?Delist Request?

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:POWDER;INHALATIONStrength0.25MG/INH
Approval Date:Sep 29, 2000TE:RLD:Yes
Patent:► SubscribePatent Expiration:Aug 23, 2016Product Flag?Substance Flag?Delist Request?

Expired Orange Book Patents for NDA: 020833

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxo Grp Ltd
FLOVENT DISKUS 50
fluticasone propionate
POWDER;INHALATION020833-001Sep 29, 2000► Subscribe► Subscribe
Glaxo Grp Ltd
FLOVENT DISKUS 50
fluticasone propionate
POWDER;INHALATION020833-001Sep 29, 2000► Subscribe► Subscribe
Glaxo Grp Ltd
FLOVENT DISKUS 100
fluticasone propionate
POWDER;INHALATION020833-002Sep 29, 2000► Subscribe► Subscribe
Glaxo Grp Ltd
FLOVENT DISKUS 250
fluticasone propionate
POWDER;INHALATION020833-003Sep 29, 2000► Subscribe► Subscribe
Glaxo Grp Ltd
FLOVENT DISKUS 50
fluticasone propionate
POWDER;INHALATION020833-001Sep 29, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Healthtrust
Covington
Fuji
Daiichi Sankyo
Chubb
Argus Health
QuintilesIMS
Baxter
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot